Placental tissue shows promise for stubborn wounds

NCT ID NCT07215741

Completed Disease control Sponsor: StimLabs Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jul 01, 2026 · Updated 3 times

Summary

This study looks at how well a product made from donated placental tissue helps close hard-to-heal wounds, such as diabetic foot ulcers and venous leg ulcers. Researchers will review medical records of 50 people who received this treatment to see how many wounds fully closed within 12 weeks. The goal is to understand if this real-world use leads to better healing outcomes.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: human placental membrane tissue (Relese)
What this could lead to: If successful, this could provide a better treatment option for people with hard-to-heal wounds, potentially leading to faster and more complete wound closure.
What could go wrong: This is a small, retrospective study without a control group, so results may not prove the treatment is better than standard care. Outcomes depend on real-world factors that are not tightly controlled.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC WOUNDS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

ulcer of lower limbs

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHRONIC WOUNDS DIABETIC ULCERS

Contacts and locations

Locations

Cypress Wound Care

Oklahoma City, Oklahoma, 73103, United States
Premier Foot & Ankle

Denison, Texas, 75020, United States
Premier Foot & Ankle

Frisco, Texas, 75033, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.